Author: | Kenneth Kee | ISBN: | 9781370353262 |
Publisher: | Kenneth Kee | Publication: | December 29, 2017 |
Imprint: | Smashwords Edition | Language: | English |
Author: | Kenneth Kee |
ISBN: | 9781370353262 |
Publisher: | Kenneth Kee |
Publication: | December 29, 2017 |
Imprint: | Smashwords Edition |
Language: | English |
This book describes Pulmonary Fibrosis, Diagnosis and Treatment and Related Diseases
“Singapore scientists have found that a protein, Interleukin 11, or IL11, causes fibrosis disease, which can lead to life-threatening conditions.
The discovery paves the way for more effective treatment against fibrosis, where the body produces excessive connective tissue in response to an injury, causing tissue scarring.
When this happens in vital organs such as the heart, kidney or lungs, it not only damages the organ, but could result in organ failure, leading to death.
Fibrotic diseases represent a major cause of illness and death around the world.
The discovery that IL11 is a critical fibrotic factor represents a breakthrough for the field and for drug development.
So if people have advanced fibrosis, that can be turned back and the organ can become healthy again.
There is a precedent that that can work, particularly in the liver, heart, lung and kidney."
Fibrosis:
The disorder fibrosis is the formation of fibrous connective tissue as a repairing response to injury or injury.
Fibrosis may refer to the connective tissue deposition that occurs as part of normal healing or to the excess tissue deposition that occurs as a pathological process.
When fibrosis occurs in reaction to damage, the word “scarring” is used.
Some of the main types of fibrosis that occur in the body are:
TABLE OF CONTENT
Introduction
Chapter 1 Pulmonary Fibrosis
Chapter 2 Causes
Chapter 3 Symptoms
Chapter 4 Diagnosis
Chapter 5 Treatment
Chapter 6 Prognosis
Chapter 7 Fibrocystic Breast Condition
Chapter 8 Liver Cirrhosis
Epilogue
This book describes Pulmonary Fibrosis, Diagnosis and Treatment and Related Diseases
“Singapore scientists have found that a protein, Interleukin 11, or IL11, causes fibrosis disease, which can lead to life-threatening conditions.
The discovery paves the way for more effective treatment against fibrosis, where the body produces excessive connective tissue in response to an injury, causing tissue scarring.
When this happens in vital organs such as the heart, kidney or lungs, it not only damages the organ, but could result in organ failure, leading to death.
Fibrotic diseases represent a major cause of illness and death around the world.
The discovery that IL11 is a critical fibrotic factor represents a breakthrough for the field and for drug development.
So if people have advanced fibrosis, that can be turned back and the organ can become healthy again.
There is a precedent that that can work, particularly in the liver, heart, lung and kidney."
Fibrosis:
The disorder fibrosis is the formation of fibrous connective tissue as a repairing response to injury or injury.
Fibrosis may refer to the connective tissue deposition that occurs as part of normal healing or to the excess tissue deposition that occurs as a pathological process.
When fibrosis occurs in reaction to damage, the word “scarring” is used.
Some of the main types of fibrosis that occur in the body are:
TABLE OF CONTENT
Introduction
Chapter 1 Pulmonary Fibrosis
Chapter 2 Causes
Chapter 3 Symptoms
Chapter 4 Diagnosis
Chapter 5 Treatment
Chapter 6 Prognosis
Chapter 7 Fibrocystic Breast Condition
Chapter 8 Liver Cirrhosis
Epilogue